Benztropine for the relief of acute non-traumatic neck pain – a randomised trial

Phase 4

Completed

• Conditions: Acute non-traumatic neck pain; Musculoskeletal - Other muscular and skeletal disorders; Anaesthesiology - Pain management

• Registration Number: ACTRN12612000354886
• Lead Sponsor: St George Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-03-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Non-traumatic neck pain of <24 hours duration
-Age 16-65

Exclusion Criteria

-Use of drugs known to cause dystonic reactions in the 24 hours prior to the onset of pain (eg metoclopramide (maxalon), prochlorperazine (stemetil), promethazine (phenergan), haloperidol)
-Clinical suspicion of a secondary cause for pain (eg neck-space infections, cervical osteomyelitis, discitis, epidural abscess, pathological cervical fractures, primary or secondary malignancies)
-Past history of cervical spine fracture
-Past history of chronic or recurrent neck pain
-Past history of cervical spine surgery
-Fever
-Focal neurological deficit
-Known allergy or adverse event to benztropine
-Anti-coagulant medication (eg warfarin or enoxaparin) or clopidogrel
-Known coagulation disorder (eg haemophilia) or platelet disorder (eg ITP, leukaemia, myelodysplastic disorder)
-Parkinsons disease
-Schizophrenia
-Pregnant women

Study & Design

• Study Type: Interventional
• Study Design: Not specified